Andrew Lister

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

Gilles Salles, John F. Seymour, Fritz Offner et al. · The Lancet · 2010 · 1.1K citations

Lymphoid Neoplasia, Oncology, Phase 3 +8

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

John Radford, Tim Illidge, Nicholas Counsell et al. · New England Journal of Medicine · 2015 · 734 citations · Full text

Follicular lymphoma international prognostic index.

Pascal Roy, Philippe Colombat, Josephine M White et al. · PubMed · 2004 · 627 citations

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

Anthony J. Swerdlow, Craig Higgins, Paul Smith et al. · JNCI Journal of the National Cancer Institute · 2007 · 444 citations

Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium

Daphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2007 · 304 citations · Full text